References
Bradley, A.M., Buie, L.W., Kuykendal, A., & Voorhees, P.M. (2012). Successful use of intrathecal carboxypeptidase G2 for intrathecal methotrexate overdose: A case study and review of the literature. Clinical Lymphoma, Myeloma, and Leukemia, 13, 166-170. doi:10.1016/j.clml.2012.09.004
Doroshow, J.H., McCoy, S., MacDonald, J.S., Issell, B.F., Patel, T., Cobb, P.W., & Abbruzzese, J.L. (2006). Phase II trial of PN401, 5-FU and leucovorin in unresectable or metastatic adenocarcinoma of the stomach: A Southwest Oncology Group study. Investigational New Drugs, 24, 537-542.
Erdlenbruch, B., Pekrun, A., Schiffmann, H., Witt, O., & Lakomek, M. (2002). Accidental cisplatin overdose in a child: Reversal of acute renal failure with sodium thiosulfate. Medical and Pediatric Oncology, 38, 349-352.
Fischer, D.S., Alfano, S., Knobf, M.T., Donovan, C., & Beaulieu, N. (1996). Improving the cancer chemotherapy use process. Journal of Clinical Oncology, 14, 3148-3155.
Goldfrank, L.R. (Ed.). (2006). Goldfrank's manual of toxicologic emergencies (8th ed.). Philadelphia, PA: McGraw-Hill.
Goodin, S., Griffith, N., Chen, B., Chuk, K., Daouphars, M., Doreau, C., … Meier, K. (2011). Safe handling of oral chemotherapeutic agents in clinical practice: Recommendations from an international pharmacy panel. Journal of Oncology Practice, 7, 7-12.
Grush, O.S., & Morgan, S.K. (1979). Folinic acid rescue for vincristine toxicity. Clinical Toxicology, 14, 71-78.
Hamadani, M., & Awan, F. (2006). Role of thiamine in managing ifosfamide-induced encephalopathy. Journal of Oncology Pharmacy Practice, 12, 237-239.
Hidalgo, M., Villalona-Calero, M., Eckhardt, S., Rodriguez, G., Hammond, L.A., Diab, S.G., … Rowinsky, E.K. (2000). Phase I and pharmacologic study of PN401 and fluorouracil in patients with advanced solid malignancies. Journal of Clinical Oncology, 18, 167.
Institute for Safe Medical Practices. (2007). Fluorouracil incident RCA: Follow-up. ISMP Canada Safety Bulletin, 7(4), 1-4.
Institute of Medicine. (2000). To err is human: Building a safer health system. Washington, DC: National Academies Press.
Jackson, D.V., Wu, W.C., & Spurr, C.L. (1982). Treatment of vincristine-Induced ileus with sincalide, a cholecytokinin analog. Cancer Chemotherapy and Pharmacology, 8, 83-85.
Katzenbach, J.R., & Smith, D.K. (1994). Wisdom of teams. New York, NY: Harper Collins.
Leu, L., & Baribeault, D. (2010). A comparison of the rates of cisplatin (cDDP)-induced nephrotoxicity associated with sodium loading or sodium loading with forced diuresis as a preventative measure. Journal of Oncology Pharmacy Practice, 16, 167-171.
Moore, J., Grasso, J., Barbarotta, L., Nelson, W., & Fischer, D.S. (2009). When prevention fails, policy for accidental chemotherapy overdose [Abstract 3678]. Retrieved from
http://www.nursinglibrary.org/vhl/handle/10755/164777
Morgan, K.P., Buie, L.W., & Savage, S.W. (2012). The role of mannitol as a nephroprotectant in patients receiving cisplatin therapy. Annals of Pharmacotherapy, 46, 276-281.
O'Marcaigh, A.S., Johnson, C.M., Smithson, W.A., Patterson, M.C., Widemann, B.C., Adamson, P.C., & McManus, M.J. (1996). Successful treatment of intrathecal methotrexate overdose by using ventriculolumbar perfusion and intrathecal instillation of carboxypeptidase G2. Mayo Clinic Proceedings, 71, 161-165.
Osborne, J., Blais, K., & Hayes, J.S. (1999). Nurses' perceptions: When is it a medication error? Journal of Nursing Administration, 29(4), 33-38.
Patel, P.N. (2006). Methylene blue for the management of Ifosfamide-induced encephalopathy. Annals of Pharmacotherapy, 40(2), 299-303.
Rahiem Ahmed, Y.A.A., & Hasan, Y. (2013). Prevention and management of high dose methotrexate toxicity. Journal of Cancer Science Therapeutics, 5(3), 106-112.
Saif, W.M., Ezzedlin, H., Vance, K., Sellers, S., & Diasio, R.B. (2007). DPYD*2A mutation: The most common mutation associated with PDP deficiency. Cancer, Chemotherapy and Pharmacology, 60, 503-507.
Solimando, D.A. (Ed.). (2012). Drug information handbook for oncology (10th ed.). Hudson, OH: Lexi-Comp.
Thomas, L.L., Brat, P.C., Somers, R., & Goudsmit, R. (1982). Massive vincristine overdose: Failure of leucovorin to reduce toxicity. Cancer Treatment Reports, 66, 1967-1969.
Vik, T., Slordahi, S., & Moe, P.J. (1985). An overdose of vincristine in an eleven-year-old boy. Pediatric Hematology-Oncology, 2, 167-170.
Wang, R.Y. (2006). Antineoplastic overview. In N.E. Flomenbaum, L.R. Goldfrank, R.S. Hoffman, M.A. Howland, N.A. Lewis, and L.S. Nelson (Eds.), Goldfrank's manual of toxicologic emergencies (8th ed., pp. 770-778). Philadelphia, PA: McGraw-Hill.
Widemann, B.C., Balis, F.M., Kim, A., Boron, M., Jayaprakash, N., Shalabi, A., … Adamson, P.C. (2010). Glucarpidase, leucovorin, and thymidine for high-dose methotrexate-induced renal dysfunction: Clinical and pharmacologic factors affecting outcome. Journal of Clinical Oncology, 28, 3979-3986.